House Rx Revenue and Competitors
Employee Data
- House Rx has 134 Employees.
- House Rx grew their employee count by 49% last year.
House Rx's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder & President | Reveal Email/Phone |
2 | Chief Pharmacy and Operating Officer | Reveal Email/Phone |
3 | Chief Staff | Reveal Email/Phone |
4 | VP - Pharmaceutical Services | Reveal Email/Phone |
5 | Head Engineering | Reveal Email/Phone |
6 | SVP, People & Talent | Reveal Email/Phone |
7 | SVP, People & Talent | Reveal Email/Phone |
8 | Head Product Design | Reveal Email/Phone |
9 | VP Product | Reveal Email/Phone |
10 | Head Marketing | Reveal Email/Phone |
House Rx Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 2 | -50% | N/A | N/A |
#2 | N/A | 32 | 28% | N/A | N/A |
#3 | $35M | 111 | 8% | N/A | N/A |
#4 | $3.5M | 102 | 28% | N/A | N/A |
#5 | $3.5M | 99 | 24% | N/A | N/A |
#6 | $35M | 59 | 7% | N/A | N/A |
#7 | $3.5M | 382 | 13% | N/A | N/A |
#8 | $1.7M | 10 | -44% | N/A | N/A |
#9 | N/A | 73 | 14% | N/A | N/A |
#10 | N/A | 107 | 15% | N/A | N/A |
What Is House Rx?
House Rx is a technology-enabled service company focused on making specialty medication more accessible and affordable. We do so by helping clinics dispense specialty medications to their patients in a medically-integrated way using pharmacist expertise and modern technology. By helping physicians and pharmacists collaborate on patient care, we’re able to improve patient outcomes, lower the cost of care, and create a better experience for patients and their caregivers.
keywords:N/AN/A
Total Funding
134
Number of Employees
N/A
Revenue (est)
49%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $26.9M | 134 | 37% | N/A |
#2 | $24.1M | 134 | -1% | N/A |
#3 | $7.5M | 134 | 29% | N/A |
#4 | $41.3M | 134 | -11% | N/A |
#5 | $43M | 134 | 5% | N/A |